|
2024
|
Invention
|
A receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy. A ... |
|
|
Invention
|
Tesofensine and metoprolol for treatment of hypertension.
The present invention relates to treat... |
|
|
Invention
|
A gaba receptor modulator for use in the treatment of absence seizures. Provided herein are metho... |
|
|
Invention
|
A gaba receptor modulator for treating disorders associated with sleep spindle deficits. Provided... |
|
|
Invention
|
Kv7 modulators. vvv7 potassium channels. |
|
|
Invention
|
Potassium channel inhibitors. The present invention relates to novel compounds, pharmaceutical co... |
|
2022
|
Invention
|
Tesofensine and beta blocker combination formulations. The present invention relates to a control... |
|
|
Invention
|
A gaba receptor modulator for use in the treatment of pain.
The present invention relates to the... |
|
|
Invention
|
A gaba receptor modulator for use in the treatment of pain. Hbb]pyridin-6-yl)propan-2-ol or a pha... |
|
2021
|
Invention
|
Novel potassium channel inhibitors.
The present invention relates to novel compounds, pharmaceut... |
|
|
Invention
|
Novel potassium channel inhibitors. The present invention relates to novel compounds, pharmaceuti... |
|
|
Invention
|
Pharmaceutical compositions for combination therapy.
This invention relates to the use of pharma... |
|
|
Invention
|
Treatment of hypothalamic obesity. The present disclosure relates to treatment of Hypothalamic Ob... |
|
2020
|
Invention
|
Tesofensine and metoprolol for treatment of hypertension. The present invention relates to treatm... |
|
|
Invention
|
Tesofensine for reduction of body weight in prader-willi patients.
The present invention relates... |
|
|
Invention
|
Tesofensine for reduction of body weight in prader-willi patients. The present invention relates ... |
|
2019
|
Invention
|
Transdermal tropane compositions and methods for using the same.
Aspects of the invention includ... |
|
|
Invention
|
Transdermal tropane compositions and methods for using the same. Aspects of the invention include... |
|
|
Invention
|
Gabaa receptor ligand. The present invention relates to 2-(3-(3-(2,4-dimethoxypyrimidin-5-yl)phen... |
|
|
Invention
|
A receptor ligand. Hbb]pyridin-6-yl)propan-2-ol, which is useful as a GABA receptor modulator. In... |
|
2018
|
Invention
|
Selective agonist of α6 containing nachrs. The present invention relates to a subtype selective p... |
|
2017
|
G/S
|
Medicine. |
|
|
Invention
|
Tesofensine compositions. The present invention relates to tesofensine compositions, methods to p... |
|
2016
|
Invention
|
A receptor complex. A receptors containing the α5 subunit. |
|
|
Invention
|
Tesofensine, beta blocker combination formulation. The present invention relates to a controlled ... |
|
2015
|
Invention
|
Pharmaceutical compositions for combination therapy. This invention relates to the use of pharmac... |
|
2013
|
Invention
|
Tetrazole derivatives and their use as potassium channel modulators. A tetrazole derivative of ge... |
|
2011
|
Invention
|
A receptor complex. A receptor complex. The compounds have the formula I:
A receptor complex, a... |
|
2009
|
Invention
|
A receptor complex. A receptor complex. In other aspects the application discloses the use of the... |
|
|
Invention
|
Method for combating adverse effects arising from antipsychotic treatment. This invention relates... |
|
2008
|
Invention
|
N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors. This inven... |
|
|
Invention
|
Carbonylamino derivatives useful for the treatment of certain inflammatory disorders. The present... |
|
|
Invention
|
Hydrochloride salt of an azabicyclo[3.2.1]octane derivative. The invention relates to a hydrochlo... |
|
2007
|
Invention
|
1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use. This invention relat... |
|
2006
|
Invention
|
Oxadiazole derivatives and their medical use. This invention relates to novel oxadiazole derivati... |
